Global Tuberculosis (TB) Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss.



Scope of the Report:

This report studies the Tuberculosis (TB) Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis (TB) Diagnostics market by product type and applications/end industries.

The increasing number of government and non-government initiatives to eradicate tuberculosis (TB) is expected to be one of the primary drivers for the global tuberculosis (TB) diagnostics market growth till 2023. A global TB control program was introduced by the US Agency for International Development (USAID) in the year 1998. To support the eradication of TB, the US prioritized and provided increased funding for bilateral and multilateral programs in the subsequent decades. Similarly, the division of tuberculosis elimination (DTBE), adopted strategic plans to control TB in the US. These programs reduce the incidence and mortality by 50%.

The increasing prevalence of TB and rising population in APAC is driving the growth prospects for the global tuberculosis (TB) diagnostics market in the region. The governments in the region are motivated to take measures to improve the healthcare infrastructure. They are also extensively focusing on the preventive care due to the rising population, especially in China and India. Furthermore, the enhancement of healthcare infrastructure in countries such as Singapore, Japan, Australia, and South Korea will boost the adoption of tuberculosis diagnostics in the APAC region.

The global Tuberculosis (TB) Diagnostics market is valued at 2040 million USD in 2017 and is expected to reach 2540 million USD by the end of 2023, growing at a CAGR of 3.7% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis (TB) Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Abbott

BD

bioMérieux

F. Hoffmann-La Roche

Thermo Fisher Scientific



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Smear Microscopy

Molecular Testing

Mantoux Tuberculin Test

Culture

Drug Susceptibility Testing

LF-LAM for PLHIV



Market Segment by Applications, can be divided into

Diagnostic Laboratories

Hospitals

Frequently Asked Questions